<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="895">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05149508</url>
  </required_header>
  <id_info>
    <org_study_id>8412</org_study_id>
    <nct_id>NCT05149508</nct_id>
  </id_info>
  <brief_title>Intraperitoneal Pressure Measurements in Children</brief_title>
  <acronym>IPM</acronym>
  <official_title>Intraperitoneal Pressure Measurements in Children: a Retrospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pediatric peritoneal dialysis is prescribed according to the type of dialysis, the volume&#xD;
      infused and the dialysis time. The measurement of intraperitoneal pressure (IPP) is an&#xD;
      important and easy indicator to perform. A IPP greater than 18 cmH20 has been correlated with&#xD;
      pain and dyspnea, a IPP greater than 14 has been correlated with a higher risk of peritonitis&#xD;
      and a IPP greater than 13 was correlated with higher mortality and a switch on hemodialysis.&#xD;
      These data suggest the importance of routine IPP measurement. Few data are available in the&#xD;
      pediatric population.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 2021</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Study of good prescribing practices in children followed by peritoneal dialysis at Strasbourg University Hospital, by intraperitoneal pressure measurements</measure>
    <time_frame>Files analysed retrospectively from January 01, 2001 to August 31, 2019 will be examined]</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">21</enrollment>
  <condition>Peritoneal Dialysis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Minor subject (&lt;18 years old) in stable peritoneal dialysis for more than 3 months and&#xD;
        having had at least 3 IPP measurements&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Minor subject (&lt;18 years old)&#xD;
&#xD;
          -  In stable peritoneal dialysis for more than 3 months&#xD;
&#xD;
          -  Subject having had at least 3 IPP measurements&#xD;
&#xD;
          -  At least 3 months after surgery to insert a peritoneal dialysis catheter&#xD;
&#xD;
          -  Subject (and / or his parental authority) not having expressed, after being informed,&#xD;
             his opposition to the reuse of his data for the purposes of this research.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
        - -Subject (or his parents) having expressed his (their) opposition to participating in the&#xD;
        stud&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>17 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Ariane ZALOSZYC, MD</last_name>
    <phone>33 3 88 12 77 49</phone>
    <email>ariane.zaloszyc@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Saïd CHAYER, PhD, HDR</last_name>
    <email>said.chayer@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service : Pédiatrie 1 - Hôpitaux Universitaires de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Ariane ZALOSZYC, MD</last_name>
      <phone>33 3 88 12 77 49</phone>
      <email>ariane.zaloszyc@chru-strasbourg.fr</email>
    </contact>
    <contact_backup>
      <last_name>Saïd CHAYER, PhD, HDR</last_name>
    </contact_backup>
    <investigator>
      <last_name>Ariane ZALOSZYC, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne-Louise SAWAYA, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 24, 2021</study_first_submitted>
  <study_first_submitted_qc>November 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 8, 2021</study_first_posted>
  <last_update_submitted>December 13, 2021</last_update_submitted>
  <last_update_submitted_qc>December 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Peritoneal Dialysis</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

